title: Using genetically engineered animal models in the postgenomic era to understand gene function in alcoholism.
abstract: Over the last 50 years, researchers have made substantial progress in identifying genetic variations that underlie the complex phenotype of alcoholism. Not much is known, however, about how this genetic variation translates into altered biological function. Genetic animal models recapitulating specific characteristics of the human condition have helped elucidate gene function and the genetic basis of disease. In particular, major advances have come from the ability to manipulate genes through a variety of genetic technologies that provide an unprecedented capacity to determine gene function in the living organism and in alcohol-related behaviors. Even newer genetic-engineering technologies have given researchers the ability to control when and where a specific gene or mutation is activated or deleted, allowing investigators to narrow the role of the gene's function to circumscribed neural pathways and across development. These technologies are important for all areas of neuroscience, and several public and private initiatives are making a new generation of genetic-engineering tools available to the scientific community at large. Finally, high-throughput "next-generation sequencing" technologies are set to rapidly increase knowledge of the genome, epigenome, and transcriptome, which, combined with genetically engineered mouse mutants, will enhance insight into biological function. All of these resources will provide deeper insight into the genetic basis of alcoholism.
authors.affiliation: Division of Neuroscience and Behavior, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Reilly
authors.forename: R Adron
authors.initials: RA
authors.lastname: Harris
authors.forename: Antonio
authors.initials: A
authors.lastname: Noronha
mesh_terms: D000437:Alcoholism / Q000235:genetics; D000818:Animals; D030801:Animals, Genetically Modified; D015415:Biomarkers; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D016678:Genome; D006801:Humans; D010641:Phenotype
chemical_list: D015415:Biomarkers